Member Info for elrico

Chips in devices. I prefer "intel inside." In other words, OPTI's LP-LDL has the potential to be the key ingredient inside cholesterol reducing supplement and pharma products. Bold reference!

Thanks GLR - I wrote the article in the link.

IC simply don't understand the business model. The funds were for SBTX not for other parts of OPTI the business. OPTI is fully funded. The £4.1 m raised for SBTX is to see it through to the end of 2018, when by it hopes to have a commercial product ready for market. It is possible it may require further funding if it sees opportunities to fast track other parts of it's IP. I don't think the 190,000 opti shares traded today had anything to to with the valuation of SBTX. Yet another reason why I won't subscribe to IC. Lazy sods!